Company news

Find out what’s going on within Adelphi Values, from new interesting people making a difference to updates on our latest work.

The Institute of Pharmaceutical Medicine at the University of Basel invited Bryan Bennett from Adelphi Values to give a lecture to students of the post-graduate ‘European Course of Pharmaceutical Medicine’, a course which is typically undertaken by pharmaceutical industry professionals. The lecture titled ‘Epidemiology and patient-reported outcome studies’ was part… Read More

Increasing numbers of rare diseases are being recognised and more medicines to treat them are being developed. There are several unique challenges for developing evidence packages in rare diseases such as the paucity of information on patient populations, disease progression and appropriate Clinical Outcome Assessments (COAs). As with all clinical… Read More

Oncology is an area that is notoriously hard to achieve patient-reported outcome label claims, but experts at Adelphi Values continue to evaluate ways to work with the FDA guidelines to ensure data are robust and stand up to the scrutiny of regulators. To demonstrate this, and in collaboration with Novartis,… Read More

We are exhibiting and presenting at the 18th Annual European Conference of ISPOR, the International Society for Pharmacoeconomics and Outcomes Research, which takes place from 9th-11th November 2015 in Milan, Italy. Representatives from each of our four practices and both the UK and US offices, will be attending the event. Read More